ADJUVANT HOLDINGS CO.,LTD. [4929.T]
TOKYO, Apr 17 (Pulse News Wire) – Adjuvant Holdings CO.,LTD. (4929.T) reported its fiscal year 2026 third quarter earnings, which showed a divergence from previous forecasts released on April 18, 2025.
Sales fell short of expectations due to declines in existing product sales across both skincare and haircare segments, despite efforts to boost sales through special promotions and marketing support for newer products. Specifically, skincare saw some growth among new users but was unable to offset overall revenue losses, while haircare experienced strong performance from certain products such as "muts totte," yet still failed to meet projected targets. As a result, total sales came in below forecasted levels by 12.6%. On the profit side, however, the company exceeded its anticipated figures.
Despite reduced gross margins due to lower sales volumes, operating expenses including sales promotion costs, personnel expenses, and IT-related fees decreased. Additionally, increased dividend income and higher gains from selling investment securities contributed to surpassing the previously announced projections for operating profit, ordinary profit, and net profit attributable to parent shareholders. In detail, the revised figures show sales of ¥1.489 billion, operating profit of ¥244 million, ordinary profit of ¥372 million, and net profit attributable to parent shareholders of ¥369 million, compared to the initial estimates of ¥1.544 billion, ¥180 million, ¥240 million, and ¥200 million respectively. The adjustments reflect a significant improvement in profitability metrics relative to last year's results.
🟢 Confidence: High AI-translated content.